- Journalists Distill News on Ebola, Licensing Midwives, and California’s Budget
- Justice Department charges 15 for $90M+ in alleged healthcare fraud, expands strike force
- UnitedHealth’s PBM names CFO
- Tennessee becomes 2nd state to ban PBMs from owning pharmacies
- Trump Bought Stock in Eli Lilly as His Policies Gave the Drugmaker a Big Boost, Documents Show
- 40% lower physician distress, 245% more violence reporting: Workforce retention strategies gaining traction
- 15 new behavioral health study findings to know
- APRN charged in $1.35M Medicare fraud scheme
- Florida woman faces charges of practicing unlicensed dentistry
- GI of the Rockies launches AI-powered care program
- Deputy injured in Indiana hospital shooting
- Legacy Health-backed insurer PacificSource to exit ACA market, pull out of Montana entirely
- Expanded federal scrutiny reshapes how hospitals govern risk, compliance
- The instability compounding the anesthesiologist shortage
- ADA proposes standards on dental cartridges, water quality
- The unraveling of prior authorization: 5 things to know
- The hospital bad debt and charity care crisis: 20 things to know
- As AI identifies more at-risk patients, health systems face a capacity challenge
- 5 GI power players
- 4 dental insurance updates to know
- Federal appeals court overturns EPA fluoride ruling: 5 notes
- What payers don’t understand about ASC spine surgery
- 3 men sentenced for $6.9M orthotic DME fraud scheme
- What will outpatient cardiology look like in 10 years?
- 15 leadership moves across 4 specialties
- Dental Medicaid disenrollment could cause $86M in added costs
- Park Dental opens Minnesota practice
- AI is about to break healthcare’s scarcity model — if we let it
- The most underrated threat in digital health
- Tennessee orthodontic practice opens 2 locations
- Justice Department charges autism care providers in $46.6M fraud case
- 14.2% of Medicaid patients received mental health ED follow-up: 4 notes
- Acting NIAID Chief Steps Down Amid Ebola, Hantavirus Concerns
- Leaders sound off on overrated ASC trends
- Dental hygienist employment reaches 222,000: State-by-state breakdown
- Vitana Pediatric & Orthodontic Partners adds 1st Maryland practice
- 10 highest-paying states for dental hygienists in 2026
- US overdose deaths decline for 3rd straight year: What it means for healthcare
- Sunscreen Confusion Puts More Americans At Risk For Melanoma
- ACAP warns final ACA rule adds further uncertainty to a market in flux
- AbbVie plots 85 summer layoffs tied to Allergan unit in California
- Quorum Health transitioning to nonprofit for financial pickup
- Women's Health Capitol Hill Day: Advocates lobby to advance budget priorities
- Europe's CHMP gives thumbs up to AZ's breast cancer drug after thumbs down from FDA adcomm
- Novartis, AbbVie plan summer layoffs on opposite coasts
- AstraZeneca, Daiichi beat Gilead to first-line TNBC with FDA nod for Datroway
- Industry Voices—From claims to compassion: Reclaiming patient advocacy in revenue cycle
- 1 In 10 U.S. Surgeons Quit Practice, Study Warns Of Shortage
- Video Game Can Detect Depression In Minutes, Study Says
- Quitting Smoking Might Lower Your Dementia Risk
- Severe Asthma Often Comes With Other Serious Health Problems
- AbbVie, GSK race up patient reputation leaderboard in the UK
- Efforts To Understand The Nation's Drugged Driving Problem Stall Under Trump
- Trump’s $50B Rural Health Bet Meets a Healthcare Desert in North Carolina
- 3 Medical Routines That Older People May Not Need
- Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
- Tyra creates awareness day with patient advocates to shine light on a rare cancer
- Machine learning-guided lifestyle plans reduce depression symptoms: 3 study notes
- Innovaccer picks up CaduceusHealth to offer end-to-end revenue cycle management
- Acadia psychiatric hospital faces abuse lawsuits
- Massachusetts behavioral health clinics to pay $1.4M to settle fraud allegations
- From 50 days to 7: How 1 system cut behavioral health intake wait times
- Hospitals allege contracted CVS Health subsidiaries pocketed their 340B savings
- Northwell hospital launches in-home behavioral health services
- RFK Jr. Fires Two Leaders Of Major U.S. Health Task Force
- Ksana Health awarded $17.9M to build behavioral health foundation model
- Lilly accuses church-linked pharmacies, wholesalers and more of running $200M+ rebate fraud scheme
- Study: Brokers increasingly recommending ICHRA to employers
- ASCO: Merck, Kelun's sac-TMT ADC combo beats Keytruda by 65% on progression in first-line lung cancer
- Common Food Preservatives Linked to Major Heart Problems
- Health Tech Weekly Rundown: Prime Healthcare expands virtual sitting tech; CVS Health studies seniors' digital health needs
- Amgen's Tavneos, facing liver injury scrutiny, gets label update in Japan as patient starts resume
- Gilead pledges 400K AmBisome doses to fight visceral leishmaniasis in expanded WHO collab
- With Voxzogo under pressure, BioMarin touts trial win in label expansion bid
- Migraine With Aura Linked To Middle-Age Stroke Risk
- Nicotine Vapes Triple Smokers' Odds Of Quitting Tobacco
- Fatty Liver Disease Increases Heart Attack Risk, Study Says
- Religious Anti-Abortion Center Finds Opportunity In Town Without OB-GYNs
- CPAP Insurance Rules Too Stringent, Deny Device Coverage To Sleep Apnea Patients Who Would Benefit
- ICE Arrests Are Separating Families. Here’s How To Plan Ahead.
- Colorado Charts Its Own Course on Vaccines Amid Federal Pullback
- OpenEvidence launches hands-free voice AI feature, expands hospital footprint with Cedars-Sinai tie-up
- Inside agency view: Ogilvy Health on AI’s ‘light speed,’ nano influencers and the rise of Ria
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- Fixing Eligibility at the Point of Care: The Missing Link in Medical Device Reimbursement Integrity
- The failure of the ‘usual suspects’ approach to life science recruitment
- The failure of the ‘usual suspects’ approach to life science recruitment
- Kennedy dismisses leaders of US Preventive Services Task Force
- Statement on Novel Exchange-Traded Funds (ETFs)
- CMS proposes rule aimed at limiting Medicaid state-directed payments
- WTW: Employers aiming to bulk up AI use for health and benefits
- Freestanding EDs, urgent care acquisition opportunities abound for HCA Healthcare
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Value, Focus, and the Future of MedTech: M&A and Divestitures are Rewriting the Strategic Playbook.
- Rollback of PFAS Drinking Water Standards Raises Safety Fears
- 'Missed risk': Women's Heart Health Summit explores gaps in research, treatment
- House and Senate Democrats move to overturn CMS’ WISeR AI prior auth pilot
- Designing an agentic, future‑ready tech roadmap for emerging pharma
- Judi Health taps Clear for its identity verification tech
- Canvas Medical unveils Canvas Studio, a customizable EMR workflow tool for clinicians
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- The Boston Children’s Experience: Hidden ICU Risk and AI-Driven De-escalation
- How specialty practices can get more out of technology investments
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Artivion Completes Endospan Acquisition, Expands Aortic Arch Portfolio With FDA-Approved NEXUS System
- Your Handwriting Could Be a Window Into Your Aging Brain
- Democratic senators share plans for Medicare home care benefit, long-term care reform
- GHO Capital, CBC Group plan to merge, forming $21B healthcare investment firm
- Ipsen details growing pains as teens transition to adult care
- Lilly, AbbVie, J&J, AZ lead an uptick in Big Pharma Q1 growth, with Novo again bringing up the rear
- MetroHealth partners with Artisight on smart hospital platform rollout
- How Do Caffeine, Alcohol, Weed, Nicotine Affect MS Symptoms?
- Once-A-Day Pill Effective In Treating Sleep Apnea Without CPAP, Clinical Trial Says
- Teens Turning To Creatine, Not Steroids, For 'Looksmaxxing'
- BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
- Gilead inks another deal with Korean API manufacturer Yuhan, this time worth $140M
- Childhood Trauma Tied to Higher Obesity Risk, But One Caring Adult Can Make A Difference
- Eroding ACA Enrollment Portends Higher Insurance Rates
- Amgen, bidding adieu to CFO, lures Galderma exec with hefty $12.4M bonus
- Watch: The Tug-of-War Over Taxpayer Dollars
- Religious Anti-Abortion Center Finds Opportunity in Town Without OB-GYNs
- CG Life appoints Collette Douaihy as chief creative officer as C-suite buildout continues
- Tarsus taps John Cena for its latest Demodex blepharitis campaign
- Statement on Proposing Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- American Aid Worker Tests Positive for Ebola After DRC Exposure
- Listen to the Latest ‘KFF Health News Minute’
- Headache Medicine: Statement on Proposing Releases for Registered Offering Reform and Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies
- More Kids Seeking Anxiety Help at Routine Doctor Visits, Study Finds
- Statement on Proposing Releases for Enhancement of Emerging Growth Company Accommodations and Simplification of Filer Status for Reporting Companies, and Registered Offering Reform
- Global MedTech Contract Manufactures Finalize Merger
- Global MedTech Contract Manufactures Finalize Merger
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Carl Zeiss Meditec Plans Up to 1,000 Job Cuts Amid Restructuring Effort
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Signatera CDx Gets FDA Nod as Companion Diagnostic for Muscle-Invasive Bladder Cancer
- Boston Scientific announces strategic investment in MiRus LLC
- Boston Scientific announces strategic investment in MiRus LLC
- Weed/Opioid Combo Doesn't Help Knee Arthritis Pain
- Losing A Parent Can Dent An Adult's Earning Power
- Ticks Can Creepy-Crawl Your House For Weeks Before Dying, Study Shows
- Kids Keep Getting Stuck in Hospitals, Even After Being Cleared For Discharge
- Short, Intense Radiation Therapy Safe For Prostate Cancer Patients
- Efforts To Understand the Nation’s Drugged Driving Problem Stall Under Trump
- Somewhere Between Cacophony and Euphony
- Ebola Outbreaks in Africa Trigger Global Health Emergency, U.S. Travel Warnings
- Rapid Weight Loss Beats Slow and Steady in New Clinical Trial
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Medtronic Bets on Cardiovascular Realignment Amid Stock Pressure and Facility Closures
- Smog Linked To Lewy Body Dementia Risk, Major Study Finds
- NYC Mold Removal Program Cut Asthma ER Cases By A Quarter, Study Says
LARA's licensing process is heavily weighted on the entry side, with very little real supervision after licensing. Dr. Farid T. Fata should never have been licensed in Michigan, and his license should have been revoked well before his arrest in 2013.
An experienced oncology nurse, Angela Swantek, interviewed at Dr. Fata's Michigan Hematology-Oncology (MHO) in 2010 and saw practices that were "plain wrong". Ms. Swantek was convinced that MHO was drugging patients solely to bill their insurance companies for extravagant fees. She filed a complaint with LARA, but got no response until 2011, when LARA sent her a form letter saying that there was no evidence to support an investigation into Fata. An MHO office manager, George Karadsheh, echoed Ms. Swantek's allegations in 2013, finally leading to Dr. Fata's arrest:
https://thecinemaholic.com/farid-fata-where-is-the-fraudster-now/
Farid Fata: Where is the Fraudster Now?
By Sounak Sengupta - June 17, 2023NBC’s ‘Dateline: Do No Harm’ follows the criminal antiques of fraudster, Dr. Farid Fata, as he was convicted of medical malpractice and other charges in August 2013 in Michigan. Rather than treating or easing the suffering of his cancer patients, he administered a combination of chemical infusions and injections with potentially harmful and deadly side effects for his financial benefit. So, how was Farid caught, and where is he now? Let’s find out.
Who is Farid Fata?
Farid T. Fata was born to a Melkite Catholic family in Lebanon in 1965. He secured a medical degree in his native country in 1992 before migrating to the United States to pursue a career in medical science. He served a residency at Maimonides Medical Center in Brooklyn, New York, from 1993 to 1996 and then as a fellow in hematology-oncology at Memorial Sloan Kettering Cancer Center in Manhattan until 1999. Farid worked as an attending physician at Geisinger Medical Center in Danville, Pennsylvania, from 2000 to 2003.
He opened his solely owned practice, Michigan Hematology-Oncology (MHO), at 543 North Main Street in 2003 in Rochester Hills, Michigan. What started as a small, single physician office expanded over the following decade and grew to six more locations — Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy, and Oak Park. Farid became a naturalized U.S. citizen in April 2009. By the time he was arrested in 2013, MHO had 16,000 historical patients and 1,700 current patients — the vast majority of whom belonged to Farid.
Court records underlined how he accomplished this astonishing growth using several means. His business documents and employee testimonies state Farid was seeing as many as 50-60 patients per day, scheduled in eight-minute increments. He employed non-licensed physicians with medical degrees from foreign countries to work them up before he saw them for five-ten minutes, billing at the two highest levels for office visits. Patients waited for hours at a time before they were ushered in.
According to an oncology supply company representative supplying most of his drugs, Farid worked on a plan to compete with large practices. His medicine orders skyrocketed in a year to over $7 million, then $16 million. He ordered in bulk at the end of quarters to reach the threshold for contractual discounts. Reports stated an average doctor in an oncology practice purchases approximately $1.5 million of drugs in a given year. However, when he was arrested, MHO bought $45 million for only three doctors.
A sentencing memorandum stated how Farid expanded his businesses to include a radiation treatment center, Michigan Radiation Institute (MRI); an in-house pharmacy at MHO’s Rochester Hills location, Vital Pharmacare (Vital); a diagnostic testing facility, United Diagnostics; and a charity located at MHO and staffed by social workers and grant writers, Swan for Life. Farid specialized in treating blood cancer and earned a sterling reputation as one of the best cancer specialists in the Detroit area.
According to the episode, he created a niche for himself with his aggressive treatment procedures that involved giving higher doses of chemotherapy drugs more frequently — he termed it the “European protocol.” Farid’s erstwhile wife, Samar, helped run the business side of his practice as Chief Executive Officer and Chief Financial Officer of his companies. According to an ensuing investigation, the federal officers termed Farid the most egregious fraudster in the history of this country.
Where is Farid Fata Now?
His misdemeanors were not solely limited to the millions of dollars he stole but also the harm he inflicted on more than 500 patients. Some of Farid’s misdemeanors include deliberately misdiagnosing patients with multiple myeloma, administering unrequired chemotherapy to patients, lying to them about the availability of alternative treatments, and ordering infusion times increased beyond what was medically necessary or advisable purely to increase his reimbursement.
The episode showed how there had been signs about his malpractice, which included a civil suit filed by a patient in 2007 and a veteran oncology nurse complaining to the state authorities in 2010. However, Farid’s schemes began to unravel in July 2013 when one of his 54-year-old patients, Monica Flagg, broke her leg and went to a suburban Detroit-area hospital for treatment. Farid, who had diagnosed her with multiple myeloma, was on vacation in Lebanon, and one of his doctors, Soe Maunglay, attended to Monica at MHO.
Soe could find no indication for the chemotherapy and supportive care medications. Reports stated he was already on notice after catching Farid lying about the clinic’s enrollment in a professional quality program. Suspicious, Soe began investigating some of Farid’s other cases, which included excessive use of rituximab and IVIG. During his probe, he contacted Farid’s practice manager, George Karadsheh, whose inspection supported Soe’s suspicions. George went to the Department of Justice and was interviewed on August 2, 2013.
The federal agents interviewed several staff members of MHO and corroborated the claims made by the whistleblowers — George and Soe. They arrested Farid and charged him with 19 counts of healthcare fraud and other crimes. Originally held on a $170,000 bond, the federal authorities discovered he and his wife had assets of $9 million not yet seized. Fearing him a flight risk, a federal judge raised Farid’s bond to $9 million. The Federal Bureau of Investigation confiscated thousands of medical charts.
They amassed evidence that he had used dishonest measures to trick the patients’ insurance companies and Medicare into paying $34 million in fraudulent and unnecessary claims. The officers also discovered that Farid took kickbacks from two local hospices and poured Medicare and private insurance proceeds into his diagnostic testing facility. They filed a 23-count indictment charging him with healthcare fraud, conspiracy to take and receive kickbacks, money laundering, and unlawfully procuring naturalization. Facing a maximum of 175 years in prison and the prospect of losing citizenship, Farid decided to take a plea deal.
He pled guilty in September 2014 to 16 federal charges — 13 counts of health care fraud, two counts of money laundering, and one count of conspiring to pay and receive kickbacks and cash payments for referring patients to a particular hospice and home health care company. He was sentenced to 45 years in federal prison and agreed to forfeit millions of dollars in assets to pay restitution to former patients or their families, approximately $17.6 million. The 58-year-old is incarcerated at Federal Correctional Institution, Williamsburg in South Carolina, and will not be released before December 2050.
What a saga. Who knew charisma/mystique could completely deceive so many people about their own health?
I also wonder how much he skewed regional/state cancer statistics. Is his fraud the reason Michigan has "hot spots" for certain types of cancer?
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.















